EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS092-24386 
Organism
Homo sapiens 
Tissue/cell
HFF 
Coordinate
chr2:97189370-97191050 
Target genes
Number: 10             
NameEnsembl ID
TF binding sites/motifs
Number: 20             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
BCL6BMA0731.1chr2:97189419-97189436GGGTTTCCTAGAATGCA-6.18
ETV6MA0645.1chr2:97190855-97190865AGCGGAAGTG+6.02
EWSR1-FLI1MA0149.1chr2:97189390-97189408GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr2:97189370-97189388GGCAGGCAGGCAGGCAGG+6.1
EWSR1-FLI1MA0149.1chr2:97189374-97189392GGCAGGCAGGCAGGCAGG+6.1
EWSR1-FLI1MA0149.1chr2:97189398-97189416GGAAGGAAGGGAAGGAAG+6.1
EWSR1-FLI1MA0149.1chr2:97189403-97189421GAAGGGAAGGAAGAAAGG+6.85
EWSR1-FLI1MA0149.1chr2:97189378-97189396GGCAGGCAGGCAGGAAGG+6.92
EWSR1-FLI1MA0149.1chr2:97189382-97189400GGCAGGCAGGAAGGAAGG+7.74
EWSR1-FLI1MA0149.1chr2:97189394-97189412GGAAGGAAGGAAGGGAAG+8.57
EWSR1-FLI1MA0149.1chr2:97189386-97189404GGCAGGAAGGAAGGAAGG+9.17
Gata1MA0035.3chr2:97190085-97190096ACAGATAAGGA-6.14
KLF5MA0599.1chr2:97190637-97190647GCCCCGCCCC+6.02
SPIBMA0081.2chr2:97190853-97190865GAAGCGGAAGTG+6.44
TFAP2CMA0524.2chr2:97190542-97190554TGCCCGAGGGCA-6.27
TFAP2CMA0524.2chr2:97190542-97190554TGCCCGAGGGCA+6.52
ZNF263MA0528.1chr2:97189396-97189417AAGGAAGGAAGGGAAGGAAGA+6.05
ZNF263MA0528.1chr2:97189395-97189416GAAGGAAGGAAGGGAAGGAAG+6.24
ZNF263MA0528.1chr2:97189391-97189412GAAGGAAGGAAGGAAGGGAAG+6.31
ZNF263MA0528.1chr2:97189399-97189420GAAGGAAGGGAAGGAAGAAAG+6.56
Number of super-enhancer constituents: 2             
IDCoordinateTissue/cell
SE_43681chr2:97190155-97206675MM1S
SE_67180chr2:97190155-97206675MM1S
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr29719038197190605
chr29718951397189979
Number: 1             
IDChromosomeStartEnd
GH02I096523chr29718941197191322
Enhancer Sequence
GGCAGGCAGG CAGGCAGGCA GGAAGGAAGG AAGGAAGGGA AGGAAGAAAG GGTTTCCTAG 60
AATGCACCAG GCCAAGACTA AGACCCAGAC CCCTCCCCAG CTATCCCAAT CTCCCTGTAG 120
TTGCTGGGGA TCCAGAGCCT GTCCTGCTCT CCCCCAGCCC AGGGTGCCCT TCCTGCCTTC 180
TCAGTGGCCG GGGTGCCCCT TTCCCTGTCT TTTTCCTGGC GTGCCCTCTG GCAAGGGAGT 240
GGGTCCTGAG CTGTGTGCAG GGTGCATGCG TGACACAGAG TGGGGTGGAA CAGAATCCCA 300
GGAAGGCTGA GCCCAGGCCC TGCCCTTCAT CCCCTGGCCC TTTCCCAGAG GAGGCACAAC 360
AAACTCAAAG AGAACGTATG GGCTCCAGAC CAAAGGTCCT TGGTTCATTG CATGCAGCTC 420
CCACGGCTGC AGCGGCTTTT ATGAGAAAGC AGCAAATCAT AAGAAAACTA TCTCCTTGGG 480
AGGACTTAAT TGGGACAGAA ACTGCAGATG GATGCCAGAT GTGCAACGGC ATCCAAACCC 540
GAGTCCCAAA TCCCCACAAA GATCCTCAGT CGACTCTCCC GATCCTTTGA CCAGGTAATA 600
AGAGTCCTAA TAGCAGTAGC AATGGCTCCA TTTCTAAAGC ACACACGGTA TGCTATGCAC 660
TGCTTTTATT TCTAGTTCCT TTCATTACCT AGAGAGGCAT TGCTCTGCAC ATTTTACAGA 720
TAAGGAAACT GAGGTTACTG AGGTTAGGTA ACTCAACCAA GGTCACATAT TTAGAAAGTG 780
GTGGAACTTT TCAAAATACT AAGTTGGGGA AATGCTCATC ATTTGTAGAA AAATTTTCAA 840
TAAGGCATAA GAACACAGGT TTCCAGTTAA CCCTCAGTTA CCCAGAAAAG TAAATTCCCC 900
AGAACGTCCT GCACATCGTG TATGCCTGTG TATGTGCATG CACTTGAATA TTCTGATTAG 960
CAGAGCTCGT GATAAACAGG CCAGACTACA GGGGAAAAAA ATGTGCAGAA ACCAGCAACC 1020
ATATTCTCCG AATTCATCGC ATGCTTGGAG ATCCCCAGGT AAAAAGTTAG CAAAACATAC 1080
CTTGTTCAAA ACAACTGGCC AAGGACGGGA TGTGAAGCAG CCACTGCTGC TAGGGGCACA 1140
GCATCCATTG GAGTTCCCTC CCCACCCCTA ACTGCCCGAG GGCAGCAGAT CCAGGGTTGC 1200
CCGGCCACCT CCCTCTCCTG ACTGCAGTGT GGGAAGAAAC GCAGGACGCT GGCAGGCACC 1260
AGACCGTGCC CCGCCCCTGA TCCACAGTGT GGCTTTGAGC ACACCACTTT CCCTCTCTGG 1320
GCCTTGGTTT TCCCATCTGT AAAATCAGGG CACAGTGAAC TGTAAAGGGC TCGGAGGGAA 1380
ATTTCATGGA CTGGTTGATG ATCCCAGGCT GCCGCCCTTT AGGAGAGGTC CTCCCTCCAG 1440
AGGGCTCTTG GACCTTGGGG ATCCCAGGTG GGAGCCTTCA TGGGAAGCGG AAGTGAGCCC 1500
TGAGACCTCT GCAGGCTTCT CTCCTACCTC TGAAAGACTG AGCAGGCAGC CTGGTGTCTC 1560
AGACACTCCT CATTTCCCTA CTTCCCTTCA ACAGGGTTAG AGTTCCTACG AAAGCTTTGC 1620
TGCCATGCAA GAAGGCAGAA TGCTCTCCCA CATGGAGACG CACCCAGACA GTCCACGGGA 1680